Literature DB >> 15659610

Neuroinflammation alters the hippocampal pattern of behaviorally induced Arc expression.

Susanna Rosi1, Victor Ramirez-Amaya, Almira Vazdarjanova, Paul F Worley, Carol A Barnes, Gary L Wenk.   

Abstract

Neuroinflammation is associated with a variety of neurological and pathological diseases, such as Alzheimer's disease (AD), and is reliably detected by the presence of activated microglia. In early AD, the highest degree of activated microglia is observed in brain regions involved in learning and memory. To investigate whether neuroinflammation alters the pattern of rapid de novo gene expression associated with learning and memory, we studied the expression of the activity-induced immediate early gene Arc in the hippocampus of rats with experimental neuroinflammation. Rats were chronically infused with lipopolysaccharide (LPS) (0.25 mug/h) into the fourth ventricle for 28 d. On day 29, the rats explored twice a novel environment for 5 min, separated by 45 or 90 min. In the dentate gyrus and CA3 regions of LPS-infused rats, Arc and OX-6 (specific for major histocompatibility complex class II antigens) immunolabeling and Arc fluorescence in situ hybridization revealed both activated microglia (OX-6 immunoreactivity) and elevated exploration-induced Arc expression compared with control-infused rats. In contrast, in the CA1 of LPS-infused rats, where there was no OX-6 immunostaining, exploration-induced Arc mRNA and protein remained similar in both LPS- and control-infused rats. LPS-induced neuroinflammation did not affect basal levels of Arc expression. Behaviorally induced Arc expression was altered only within the regions showing activated microglia (OX-6 immunoreactivity), suggesting that neuroinflammation may alter the coupling of neural activity with macromolecular synthesis implicated in learning and plasticity. This activity-related alteration in Arc expression induced by neuroinflammation may contribute to the cognitive deficits found in diseases associated with inflammation, such as AD.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15659610      PMCID: PMC6725337          DOI: 10.1523/JNEUROSCI.4469-04.2005

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  38 in total

1.  Environment-specific expression of the immediate-early gene Arc in hippocampal neuronal ensembles.

Authors:  J F Guzowski; B L McNaughton; C A Barnes; P F Worley
Journal:  Nat Neurosci       Date:  1999-12       Impact factor: 24.884

Review 2.  Energetics in the pathogenesis of neurodegenerative diseases.

Authors:  M F Beal
Journal:  Trends Neurosci       Date:  2000-07       Impact factor: 13.837

3.  Inhibition of activity-dependent arc protein expression in the rat hippocampus impairs the maintenance of long-term potentiation and the consolidation of long-term memory.

Authors:  J F Guzowski; G L Lyford; G D Stevenson; F P Houston; J L McGaugh; P F Worley; C A Barnes
Journal:  J Neurosci       Date:  2000-06-01       Impact factor: 6.167

Review 4.  How do cell assemblies encode information in the brain?

Authors:  Y Sakurai
Journal:  Neurosci Biobehav Rev       Date:  1999       Impact factor: 8.989

5.  Selective targeting of newly synthesized Arc mRNA to active synapses requires NMDA receptor activation.

Authors:  O Steward; P F Worley
Journal:  Neuron       Date:  2001-04       Impact factor: 17.173

6.  Quantitative volumetric analyses of brain magnetic resonance imaging from rat with chronic neuroinflammation.

Authors:  B Hauss-Wegrzyniak; J P Galons; G L Wenk
Journal:  Exp Neurol       Date:  2000-10       Impact factor: 5.330

7.  The cytotoxicity of chronic neuroinflammation upon basal forebrain cholinergic neurons of rats can be attenuated by glutamatergic antagonism or cyclooxygenase-2 inhibition.

Authors:  L B Willard; B Hauss-Wegrzyniak; W Danysz; G L Wenk
Journal:  Exp Brain Res       Date:  2000-09       Impact factor: 1.972

Review 8.  Inflammation and Alzheimer's disease.

Authors:  H Akiyama; S Barger; S Barnum; B Bradt; J Bauer; G M Cole; N R Cooper; P Eikelenboom; M Emmerling; B L Fiebich; C E Finch; S Frautschy; W S Griffin; H Hampel; M Hull; G Landreth; L Lue; R Mrak; I R Mackenzie; P L McGeer; M K O'Banion; J Pachter; G Pasinetti; C Plata-Salaman; J Rogers; R Rydel; Y Shen; W Streit; R Strohmeyer; I Tooyoma; F L Van Muiswinkel; R Veerhuis; D Walker; S Webster; B Wegrzyniak; G Wenk; T Wyss-Coray
Journal:  Neurobiol Aging       Date:  2000 May-Jun       Impact factor: 4.673

9.  Arg3.1/Arc mRNA induction by Ca2+ and cAMP requires protein kinase A and mitogen-activated protein kinase/extracellular regulated kinase activation.

Authors:  R Waltereit; B Dammermann; P Wulff; J Scafidi; U Staubli; G Kauselmann; M Bundman; D Kuhl
Journal:  J Neurosci       Date:  2001-08-01       Impact factor: 6.167

10.  CXCR4-activated astrocyte glutamate release via TNFalpha: amplification by microglia triggers neurotoxicity.

Authors:  P Bezzi; M Domercq; L Brambilla; R Galli; D Schols; E De Clercq; A Vescovi; G Bagetta; G Kollias; J Meldolesi; A Volterra
Journal:  Nat Neurosci       Date:  2001-07       Impact factor: 24.884

View more
  68 in total

1.  Involvement of CLEC16A in activation of astrocytes after LPS treated.

Authors:  Xinmin Wu; Jing Li; Chun Chen; Yaohua Yan; Shengyang Jiang; Xiaohong Wu; Bai Shao; Jin Xu; Lihua Kang; Yeqing Huang; Lin Zhu; Yuhong Ji; Yilu Gao
Journal:  Neurochem Res       Date:  2011-10-15       Impact factor: 3.996

2.  Trauma-induced alterations in cognition and Arc expression are reduced by previous exposure to 56Fe irradiation.

Authors:  Susanna Rosi; Karim Belarbi; Ryan A Ferguson; Kelly Fishman; Andre Obenaus; Jacob Raber; John R Fike
Journal:  Hippocampus       Date:  2010-12-29       Impact factor: 3.899

3.  Human neural stem cell transplantation ameliorates radiation-induced cognitive dysfunction.

Authors:  Munjal M Acharya; Lori-Ann Christie; Mary L Lan; Erich Giedzinski; John R Fike; Susanna Rosi; Charles L Limoli
Journal:  Cancer Res       Date:  2011-07-14       Impact factor: 12.701

4.  Cranial irradiation alters the behaviorally induced immediate-early gene arc (activity-regulated cytoskeleton-associated protein).

Authors:  Susanna Rosi; Marta Andres-Mach; Kelly M Fishman; William Levy; Ryan A Ferguson; John R Fike
Journal:  Cancer Res       Date:  2008-12-01       Impact factor: 12.701

5.  Anti-inflammatory property of the cannabinoid agonist WIN-55212-2 in a rodent model of chronic brain inflammation.

Authors:  Y Marchalant; S Rosi; G L Wenk
Journal:  Neuroscience       Date:  2006-12-18       Impact factor: 3.590

6.  Accuracy of hippocampal network activity is disrupted by neuroinflammation: rescue by memantine.

Authors:  S Rosi; V Ramirez-Amaya; A Vazdarjanova; E E Esparza; P B Larkin; J R Fike; G L Wenk; C A Barnes
Journal:  Brain       Date:  2009-06-16       Impact factor: 13.501

Review 7.  "Boomerang Neuropathology" of Late-Onset Alzheimer's Disease is Shrouded in Harmful "BDDS": Breathing, Diet, Drinking, and Sleep During Aging.

Authors:  Mak Adam Daulatzai
Journal:  Neurotox Res       Date:  2015-04-25       Impact factor: 3.911

8.  The brain expression of genes involved in inflammatory response, the ribosome, and learning and memory is altered by centrally injected lipopolysaccharide in mice.

Authors:  R H Bonow; S Aïd; Y Zhang; K G Becker; F Bosetti
Journal:  Pharmacogenomics J       Date:  2008-10-28       Impact factor: 3.550

9.  Potent anti-inflammatory and neuroprotective effects of TGF-beta1 are mediated through the inhibition of ERK and p47phox-Ser345 phosphorylation and translocation in microglia.

Authors:  Li Qian; Sung-Jen Wei; Dan Zhang; Xiaoming Hu; Zongli Xu; Belinda Wilson; Jamel El-Benna; Jau-Shyong Hong; Patrick M Flood
Journal:  J Immunol       Date:  2008-07-01       Impact factor: 5.422

10.  CCR2 deficiency prevents neuronal dysfunction and cognitive impairments induced by cranial irradiation.

Authors:  Karim Belarbi; Timothy Jopson; Carla Arellano; John R Fike; Susanna Rosi
Journal:  Cancer Res       Date:  2012-12-13       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.